Roche delays $4.3B Spark buyout — again — as FTC review drags on
The Roche/Spark deal is still happening. On time. It’s just going to take a little longer.
So says the Swiss giant, which has extended its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
